drugset / Trial / NCT02032485

Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer

NCT02032485

Phase 2 Completed 10 enrolled Jules Bordet Institute
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine if Near-Infrared fluorescence imaging is an effective approach to detect the colorectal tumoral tissues and peritoneal implants in colorectal cancer patients.

Timeline

Start
2013-03
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.125 mg/kg Intravenous
Subject Indocyanine Green Diagnostic / imaging agent 0.25 mg/kg Intravenous